182 related articles for article (PubMed ID: 31338558)
1. Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.
Tian MX; Zhou YF; Qu WF; Liu WR; Jin L; Jiang XF; Wang H; Tao CY; Zhou PY; Fang Y; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
Cancer Immunol Immunother; 2019 Aug; 68(8):1369-1378. PubMed ID: 31338558
[TBL] [Abstract][Full Text] [Related]
2. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
3. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study.
Zhang Z; Zhou Y; Hu K; Wang D; Wang Z; Huang Y
BMC Cancer; 2020 Mar; 20(1):270. PubMed ID: 32228636
[TBL] [Abstract][Full Text] [Related]
4. Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study.
Yin X; Zheng SS; Zhang BH; Zhou Y; Chen XH; Ren ZG; Qiu SJ; Fan J
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1408-14. PubMed ID: 23839159
[TBL] [Abstract][Full Text] [Related]
5. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
[TBL] [Abstract][Full Text] [Related]
7. Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS
Tian M; Liu W; Tao C; Tang Z; Zhou Y; Song S; Jin L; Wang H; Jiang X; Zhou P; Fang Y; Qu W; Ding Z; Peng Y; Fu X; Qiu S; Zhou J; Fan J; Shi Y
Cancer Sci; 2020 Apr; 111(4):1084-1092. PubMed ID: 31971309
[TBL] [Abstract][Full Text] [Related]
8. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
9. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy.
Chen LP; Li C; Wang C; Wen TF; Yan LN; Li B
Hepatogastroenterology; 2012 Sep; 59(118):1765-8. PubMed ID: 22369746
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
Chen YL; Jeng YM; Hsu HC; Lai HS; Lee PH; Lai PL; Yuan RH
Int J Surg; 2013; 11(1):85-91. PubMed ID: 23246869
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
13. Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma.
Si A; Li J; Xiang H; Zhang S; Bai S; Yang P; Zhang X; Xia Y; Wang K; Yan Z; Lau WY; Shi L; Shen F
Oncotarget; 2017 Jul; 8(27):44521-44532. PubMed ID: 28562348
[TBL] [Abstract][Full Text] [Related]
14. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
[TBL] [Abstract][Full Text] [Related]
16. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China.
Chen Y; Liu H; Zhang J; Wu Y; Zhou W; Cheng Z; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zeng Y; Liu J
BMC Cancer; 2021 Dec; 21(1):1299. PubMed ID: 34863147
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of gamma-glutamyl transpeptidase to albumin ratio in patients with intrahepatic cholangiocarcinoma after hepatectomy.
Li H; Liu R; Li J; Li J; Wu H; Wang G; Li Z; Li D
J Cell Mol Med; 2022 Jun; 26(11):3196-3202. PubMed ID: 35481993
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.
Sha M; Jeong S; Wang X; Tong Y; Cao J; Sun HY; Xia L; Xu N; Xi ZF; Zhang JJ; Kong XN; Xia Q
BMC Cancer; 2019 Mar; 19(1):208. PubMed ID: 30849953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
